Joshua Reynolds, MA CCC-SLP | |
4119 Wimbledon Cir, Lawrence, KS 66047-2012 | |
(785) 280-0436 | |
Not Available |
Full Name | Joshua Reynolds |
---|---|
Gender | Male |
Speciality | Speech-language Pathologist |
Location | 4119 Wimbledon Cir, Lawrence, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356702450 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 3857 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joshua Reynolds, MA CCC-SLP 4119 Wimbledon Cir, Lawrence, KS 66047-2012 Ph: () - | Joshua Reynolds, MA CCC-SLP 4119 Wimbledon Cir, Lawrence, KS 66047-2012 Ph: (785) 280-0436 |
News Archive
According to a March 2009 study by the Environmental Protection Agency, 61 percent of the children's bath products tested were found to contain formaldehyde and 1,4-dioxane, both of which are probable carcinogens.
A heroin crisis gripping communities across the country deepened in New York last year, with more people in the city dying in overdoses from the drug than in any year since 2003. In all, 420 people fatally overdosed on heroin in 2013 out of a total of 782 drug overdoses, rising to a level not seen in a decade in both absolute numbers and as a population-adjusted rate, according to preliminary year-end data from the city's health department (Goodman, 8/28).
The Family Larsson-Rosenquist Foundation and The University of Western Australia have just released a new clinical tool to help medical practitioners resolve lactation challenges and support breastfeeding mothers: LactaMap (www.LactaMap.com).
Spectral Diagnostics Inc. and BioMS Medical Corp. today announced that BioMS Medical ("BioMS") and a syndicate of investors have invested $14 million in Spectral Diagnostics ("Spectral", or the "Company") to advance Toraymyxin(TM), a treatment for severe sepsis, towards regulatory approval and commercialization in the United States.
Roche's xCELLigence RTCA System is being used in the European Union's SEURAT (Safety Evaluation Ultimately Replacing Animal Testing) initiative to run five years from 2011 to 2016.
› Verified 2 days ago
Mrs. Laura Elaine Larson, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1600 Kentucky St, #3, Lawrence, KS 66044 Phone: 785-979-5697 | |
Dr. Betty Louise Bunce, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 Sunnyside Ave, 2101 Haworth Hall, Lawrence, KS 66045 Phone: 785-864-4690 Fax: 785-864-5094 | |
Meredith Adler, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Harvard Rd, Suite 101, Lawrence, KS 66049 Phone: 785-842-0656 Fax: 785-842-0071 | |
Lindsay Williams, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 507 Yorkshire Dr, Lawrence, KS 66049 Phone: 971-998-4192 | |
Hannah Elise Powell, MA SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 321 Tallgrass Ct, Lawrence, KS 66049 Phone: 785-643-2381 | |
Christine Michele Kosirog, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Harvard Rd, Suite 101, Lawrence, KS 66049 Phone: 785-842-0656 | |
Jana Michelle Wallen, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3200 Mesa Way Ste D, Lawrence, KS 66049 Phone: 785-831-3053 |